Among patients with COPD, those receiving 6-week nicotinamide riboside, “a B3-like vitamin,” had significantly decreased lung inflammation, according to results published in Nature Aging.In a ...

Sanofi, Regeneron's IL-33 drug fails one of 2 COPD studies as FDA timeline thrown in doubt. By James Waldron May 30, 2025 5:30am. Sanofi Regeneron Pharmaceuticals chronic ...